Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality

Prostate

Volumn 72, Issue 2, 2012, Pages 209-216

  Shui, Irene M ^a   Stark, Jennifer R ^a,b,c   Penney, Kathryn L ^a,b   Schumacher, Fredrick R ^d   Epstein, Mara M ^a,b   Pitt, Michael J ^b   Stampfer, Meir J ^a,b   Tamimi, Rulla M ^a,b   Lindstrom, Sara ^a   Sesso, Howard D ^e   Fall, Katja ^a,f   Ma, Jing ^b   Kraft, Peter ^a   Giovannucci, Edward ^a,b   Mucci, Lorelei A ^a,b,g  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ÖREBRO UNIVERSITY   (Sweden)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY OF ICELAND   (Iceland)

Author keywords

inflammation; molecular epidemiology; prostate cancer; TLR4

Indexed keywords

TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISTANT METASTASIS; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TOLL-LIKE RECEPTOR 4; UNITED STATES;

EID: 84455192192     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21423     Document Type: Article

References (14)

1. Platz EA, De Marzo AM,. Epidemiology of inflammation and prostate cancer. J Urol 2004; 171 (2 Pt 2): S36-S40. (Pubitemid 38090420)
2. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG,. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7 (4): 256-269. (Pubitemid 46486616)
3. Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, Nelson WG,. Prostate carcinogenesis and inflammation: Emerging insights. Carcinogenesis 2005; 26 (7): 1170-1181. (Pubitemid 41417894)
4. Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G,. Cancers take their Toll-The function and regulation of Toll-like receptors in cancer cells. Oncogene 2008; 27 (2): 225-233.
5. Gatti G, Quintar AA, Andreani V, Nicola JP, Maldonado CA, Masini-Repiso AM, Rivero VE, Maccioni M,. Expression of toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer. Prostate 2009; 69 (13): 1387-1397.
6. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P,. The toll-like receptor pathway: A novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008; 68 (2): 223-229. (Pubitemid 351186234)
7. Pei Z, Lin D, Song X, Li H, Yao H,. TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3cells induced by lipopolysaccharide. Cell Immunol 2008; 254 (1): 20-27.
8. Cheng I, Plummer SJ, Casey G, Witte JS,. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16 (2): 352-355. (Pubitemid 46383358)
9. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Gronberg H,. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: Results from the CAncer Prostate in Sweden Study. Cancer Res 2004; 64 (8): 2918-2922. (Pubitemid 38500633)
10. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ,. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005; 65 (24): 11771-11778. (Pubitemid 41821739)
11. Lindstrom S, Hunter DJ, Gronberg H, Stattin P, Wiklund F, Xu J, Chanock SJ, Hayes R, Kraft P,. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol Biomarkers Prev 19 (3): 873-876.
12. Stark JR, Wiklund F, Gronberg H, Schumacher F, Sinnott JA, Stampfer MJ, Mucci LA, Kraft P,. Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2009; 18 (6): 1859-1863.
13. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321 (3): 129-135.
14. Gao X, Starmer J, Martin ER,. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008; 32 (4): 361-369. (Pubitemid 351656307)